Gene Expression Profiling Is a Strong Predictor of Clinical Outcomes in Newly Diagnosed Multiple Myeloma

被引：0
|
作者：
Claussen, Catherine M.
Chuang, Tammy
Chaudhry, Maria
Lee, Hans C.
Patel, Krina K.
Bashir, Qaiser
Parmar, Simrit
Ahmed, Sairah
Mehta, Rohtesh S.
Thomas, Sheeba K.
Richards, Tiffany A.
Nieto, Yago
Shpall, Elizabeth J.
Qazilbash, Muzaffar H.
Amini, Behrang
Davis, Richard E.
Neelapu, Sattva S.
Weber, Donna M.
Orlowski, Robert Z.
Feng, Lei
Manasanch, Elisabet E.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4365
引用
收藏
页数：2
相关论文
共 50 条
  • [21] C-MYC Expression In Newly Diagnosed Multiple Myeloma
    Szabo, Agoston Gyula
    Gang, Anne Ortved
    Pedersen, Mette Olgod
    Poulsen, Tim Svenstrup
    Klausen, Tobias Wirenfeldt
    Norgaard, Peter H.
    [J]. BLOOD, 2013, 122 (21)
  • [22] The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma
    Samrat Roy Choudhury
    Cody Ashby
    Ruslana Tytarenko
    Michael Bauer
    Yan Wang
    Shayu Deshpande
    Judith Den
    Carolina Schinke
    Maurizio Zangari
    Sharmilan Thanendrarajan
    Faith E. Davies
    Frits van Rhee
    Gareth J. Morgan
    Brian A. Walker
    [J]. Journal of Hematology & Oncology, 13
  • [23] The functional epigenetic landscape of aberrant gene expression in molecular subgroups of newly diagnosed multiple myeloma
    Choudhury, Samrat Roy
    Ashby, Cody
    Tytarenko, Ruslana
    Bauer, Michael
    Wang, Yan
    Deshpande, Shayu
    Den, Judith
    Schinke, Carolina
    Zangari, Maurizio
    Thanendrarajan, Sharmilan
    Davies, Faith E.
    van Rhee, Frits
    Morgan, Gareth J.
    Walker, Brian A.
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [24] Gene expression profiling of myeloma cells to predict response to primary therapy with thalidomide. Dexamethasone for newly diagnosed multilple myeloma
    Abdelkefi, Abderrahman
    de Vos, John
    Assou, Said
    Ben Othman, Tarek
    Rossi, Jean-Francois
    Ladeb, Saloua
    Safra, Ines
    Galai, Yosr
    Ben Ahmed, Malika
    Benkahla, Alia
    Jenhani, Faouzi
    Ben Nasr, Moufida
    Torjman, Lamia
    Lakhal, Amel
    Louzir, Hechim
    Ben Abdeladhim, Abdeladhim
    [J]. BLOOD, 2007, 110 (11) : 447A - 447A
  • [25] Clinical value of molecular subtyping multiple myeloma using gene expression profiling
    N Weinhold
    C J Heuck
    A Rosenthal
    S Thanendrarajan
    C K Stein
    F Van Rhee
    M Zangari
    A Hoering
    E Tian
    F E Davies
    B Barlogie
    G J Morgan
    [J]. Leukemia, 2016, 30 : 423 - 430
  • [26] Clinical value of molecular subtyping multiple myeloma using gene expression profiling
    Weinhold, N.
    Heuck, C. J.
    Rosenthal, A.
    Thanendrarajan, S.
    Stein, C. K.
    Van Rhee, F.
    Zangari, M.
    Hoering, A.
    Tian, E.
    Davies, F. E.
    Barlogie, B.
    Morgan, G. J.
    [J]. LEUKEMIA, 2016, 30 (02) : 423 - 430
  • [27] Effect of Expression of Multidrug Resistance Genes in Newly Diagnosed Multiple Myeloma on the Clinical Course of the Disease
    Chernykh, Yulia
    Golenkov, Anatoly
    Vysotskaya, Lyudmila
    Shushanov, Sain
    Rybalkina, Ekaterina
    [J]. BLOOD, 2016, 128 (22)
  • [28] Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients
    Al Saleh, Abdullah S.
    Sidiqi, M. Hasib
    Dispenzieri, Angela
    Kapoor, Prashant
    Muchtar, Eli
    Buadi, Francis K.
    Warsame, Rahma
    Lacy, Martha Q.
    Dingli, David
    Leung, Nelson
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis V.
    Gertz, Morie A.
    Go, Ronald S.
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (01) : 4 - 9
  • [29] Can bisphosphonates improve outcomes in patients with newly diagnosed multiple myeloma?
    Morgan, Gareth J.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 77 : S24 - S30
  • [30] Newly diagnosed multiple myeloma.
    Weber D.M.
    [J]. Current Treatment Options in Oncology, 2002, 3 (3) : 235 - 245
12345